United Kingdom· GB-APID-42309611000001104
Tigecycline 50mg powder for solution for infusion vials
A tigecycline product containing tigecycline, registered in United Kingdom by Accord-UK Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Tigecycline is registered in 17 of 19 countries.
Countries holding a registration under ATC J01AA12 (tigecycline), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Tigecycline · ATC J01AA12
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tigecycline costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tigecycline · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- FI Finland$3.05
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Tigecycline
- Manufacturer
- Accord-UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- J01AA12
- ATC class
- Tigecycline
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin05055565766545
- gtin5055565766545
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
65 interactions on record for tigecycline.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tigecycline · interactions on record
65 records
- 3 severe
- 13 moderate
- 24 info
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- Sodium picosulfateA06AB08moderate
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tigecycline in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTIGECYCLINE ACCORDAccord Healthcare S.L.U., Barcelona
- SpainTIGECICLINA ACCORD 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- PolandTigecycline AccordAccord Healthcare S.L.U.
- FinlandTigecycline AccordAccord Healthcare S.L.U.
- SwedenTigecycline Accord 50 mg Pulver till infusionsvätska, lösningAccord Healthcare S.L.U.
- IrelandTigecycline 50 mg Powder for solution for infusionNoridem Enterprises Limited
- BelgiumTigecyclin Sandoz 50 mgSandoz
- IcelandTigecycline AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Tigecyclin Aptapharma, Tigecyclin Hikma
- Bulgaria · Тигециклин Аптафарма, Тигециклин Ромфарм
- Cyprus · Tigecycline Aptapharma, Tigecycline Sapiens
- Czechia · Tigecycline Aptapharma, Tigecycline Mylan
- Germany · Tigecyclin Amarox, Tigecyclin Carinopharm
- Denmark · Tigecycline Eql Pharma
- Estonia · Tigecycline Inteli, Tigecycline Norameda
- Spain · Tigeciclina Cipla, Tigeciclina Hikma
- Finland · Tigecycline Eql Pharma, Tigecycline Norameda
- France · Tigecycline Amarox, Tigecycline Hikma
- Greece · Digazor, Tigecycline Anfarm
- Croatia · Tigeciklin Aptapharma, Tigeciklin Galenika
- Hungary · Tigeciklin Galenika, Tigeciklin Noridem
- Ireland · Tigecycline Noridem Enterprises
- Iceland · Tigecycline Accord, Tygacil
- Italy · Tigeciclina Amarox, Tigeciclina Cipla
- Liechtenstein · Tigecycline Accord, Tygacil
- Lithuania · Tigecycline Inteli, Tigecycline Norameda
- Latvia · Tigecycline Inteli, Tigecycline Norameda
- Malta · Tigecycline Anfarm, Tigecycline Aptapharma
- Netherlands · Tigecycline Amarox, Tigecycline Hikma
- Norway · Tigecycline Accord, Tigecycline Eql Pharma
- Poland · Tigecycline Aptapharma, Tigecycline Norameda
- Portugal · Tigeciclina Cipla, Tigeciclina Hikma
- Romania · Tigeciclină Aptapharma, Tigeciclina Atb
- Sweden · Tigecycline Eql Pharma, Tigecycline Viatris
- Slovenia · Tigeciklin Aptapharma, Tigeciklin Diagonalis
- Slovakia · Tigecycline Aptapharma, Tigecycline Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a71d31f7-df45-4a87-931d-43ad6d48128f GET /v1/drugs/a71d31f7-df45-4a87-931d-43ad6d48128f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42309611000001104",
"desc": "Tigecycline 50mg powder for solution for infusion vials (Accord-UK Ltd)",
"form": "Powder for solution for infusion",
"vpid": "10328711000001100",
"source": "dmd",
"vtm_id": "777769009",
"strength": "50 mg",
"substance": "Tigecycline",
"ingredient": "Tigecycline",
"supplier_code": "18471011000001103"
}See everything about tigecycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.